http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013189474-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d779448e816f508915ebf0e60c0ba809
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0057
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-409
filingDate 2013-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbdb4155f7d6c8e32d1a39dd1e621872
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0886b0672a3872004242bb8d8ad6ef72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54d01a18462a717178e32c3789bc3703
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39b106781eb358c7c37c0fb9f0012c5b
publicationDate 2013-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2013189474-A
titleOfInvention Models and methods for inhibiting angiogenesis
abstract Provided are a model and a method for inhibiting angiogenesis. The present invention relates to the formation of neovasculature while maintaining the viability of the underlying tissue by subjecting a subject whose angiogenesis is to be inhibited to a sublethal dose of photodynamic therapy. A method of inhibiting is provided. The present invention also provides a model for evaluating sublethal dose PDT protocols to inhibit angiogenesis in specific target tissues. The present invention provides a method of treatment based on the discovery that PDT inhibits the formation of neovascular structures under conditions in which the viability of the underlying tissue is maintained. [Selection figure] None
priorityDate 1998-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9524930-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422603415
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00764
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00775
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35051
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81071
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97399
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID150009356
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35049
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35034
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70059
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35050
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83348
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35048
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00761
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415728619
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397481
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360596
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154438332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448365594
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485223053
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51588
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280961
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59149
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23662274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433567920
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5864210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426391190
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19799
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23916
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419529050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281377
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490899

Total number of triples: 60.